The Real Effects of Secondary Markets on Innovation

54 Pages Posted: 14 Mar 2019 Last revised: 27 Oct 2020

See all articles by Chris Mace

Chris Mace

UT Dallas, Naveen Jindal School of Management

Date Written: October 26, 2020

Abstract

In theory, financial markets promote innovation by selectively allocating capital to high-quality projects. In this paper, I show that secondary markets can inhibit innovation by permanently delaying option exercise and reducing a firm's ability to allocate capital efficiently. I find that short-term equity market declines cause pharmaceutical companies to abandon early-stage drug developments irrespective of drug quality or changes in a firm's stock price. I show that discount rate changes and financing constraints drive this behavior. My results demonstrate that even short-term market fluctuations can have long-term effects on pharmaceutical innovation and prevent potentially life-saving drugs from progressing to the market.

Keywords: Investment, Innovation, Market Downturns, Secondary Markets, Pharmaceutical Industry

JEL Classification: C26, D53, E44, G01, G14, G32, O16, O32

Suggested Citation

Mace, Chris, The Real Effects of Secondary Markets on Innovation (October 26, 2020). Available at SSRN: https://ssrn.com/abstract=3348102 or http://dx.doi.org/10.2139/ssrn.3348102

Chris Mace (Contact Author)

UT Dallas, Naveen Jindal School of Management ( email )

800 W Campbell Rd
ATTN: Christopher Mace JSOM 14.506
Richardson, TX 84112-9303
United States
+1 972-883-2382 (Phone)

HOME PAGE: http://https://jindal.utdallas.edu/faculty/christopher-mace

Do you want regular updates from SSRN on Twitter?

Paper statistics

Downloads
203
Abstract Views
1,239
rank
204,162
PlumX Metrics